Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12

Trial Status

Recruiting3
Terminated1
Other2

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT06289582Early Phase 1Recruiting
Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)
Parkinson Disease
PrincipalinvestigatorStart date: 2024-08-14
NCT04332588Phase 1Recruiting
Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI
HER2-positive Breast Cancer
PrincipalinvestigatorStart date: 2022-03-25
NCT03451123Early Phase 1Terminated
FET-PET/MRI for Surgical Assessment of Pediatric Brain Tumors
Pediatric Brain Tumors
PrincipalinvestigatorStart date: 2018-04-23
NCT05676489Early Phase 1Not Yet Recruiting
MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors
Brain Metastases From Extra-cranial Solid TumorsHealthy VolunteersRecurrent Glioma
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David Standaert, MD, PhD

University of Alabama at Birmingham

Related
1 trials

Shared therapeutic areas:

Parkinson Disease

Worked with same sponsors:

Michael J. Fox Foundation for Parkinson's ResearchUniversity of Alabama at Birmingham
Collaborated on 1 trial
Similarity Score14%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Healthy VolunteersOvary Cancer
Similarity Score8%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

Healthy VolunteersParkinson Disease
Similarity Score8%

Mark Hallett, M.D.

National Institute of Neurological Disorders and Stroke (NINDS)

Related
35 trials

Shared therapeutic areas:

Healthy VolunteersParkinson Disease
Similarity Score8%

Paolo Bonato, PhD

Spaulding Rehabilitation Hospital

Related
19 trials

Shared therapeutic areas:

Healthy Volunteers

Worked with same sponsors:

Michael J. Fox Foundation for Parkinson's Research
Similarity Score4%

Herbert B Slade, MD

Healthpoint

Related
18 trials

Shared therapeutic areas:

Healthy Volunteers
Similarity Score4%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Parkinson Disease
Similarity Score4%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score4%

Suman Sheraz, PhD*

Riphah International University

Related
21 trials

Shared therapeutic areas:

Healthy Volunteers
Similarity Score4%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT06289582Early Phase 1PrincipalInvestigator

Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)

Parkinson Disease
Recruiting
NCT05656105Early Phase 1PrincipalInvestigator

Positron Emission Tomography (PET) Imaging of Neuroinflammation in Patients With Neurological Dysfunction After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2) Infection

SARS CoV-2 Post-Acute Sequelae
Recruiting
NCT04332588Phase 1PrincipalInvestigator

Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI

HER2-positive Breast Cancer
Recruiting
NCT03451123Early Phase 1PrincipalInvestigator

FET-PET/MRI for Surgical Assessment of Pediatric Brain Tumors

Pediatric Brain Tumors
Terminated
NCT04542603Phase 1PrincipalInvestigator

Neuroinflammation and Age-associated Brain Pathology: Two Potential Mechanisms of Cognitive Impairment in Ovarian Cancer

Ovarian Cancer
Withdrawn
NCT05676489Early Phase 1PrincipalInvestigator

MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors

Brain Metastases From Extra-cranial Solid TumorsHealthy VolunteersRecurrent Glioma
Not Yet Recruiting

All 6 trials loaded